Adina Nemes

The Oncology Institute Prof. Dr. Ion Chiricuță Cluj Napoca, 40015 Cluj Napoca
Cluj-napoca, CJ, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Complications of Port-a-Cath Systems: An Institutional Study on Romanian Oncological Patients.

Complications of Port-a-Cath Systems: An Institutional Study on Romanian Oncological Patients.

Journal: Cancers

Published: December 01, 2025

Buccodental Toxicities Induced by Tyrosine Kinase Inhibitors in Patients Diagnosed with Renal Cell Carcinoma-A Literature Review.

Buccodental Toxicities Induced by Tyrosine Kinase Inhibitors in Patients Diagnosed with Renal Cell Carcinoma-A Literature Review.

Journal: Dentistry journal

Published: August 11, 2025

Serum Calcium Level at Diagnosis Can Predict Lethal Prostate Cancer Relapse.

Serum Calcium Level at Diagnosis Can Predict Lethal Prostate Cancer Relapse.

Journal: Journal of clinical medicine

Published: July 27, 2024

Concomitant Administration of Psychotropic and Prostate Cancer Drugs: A Pharmacoepidemiologic Study Using Drug-Drug Interaction Databases.

Concomitant Administration of Psychotropic and Prostate Cancer Drugs: A Pharmacoepidemiologic Study Using Drug-Drug Interaction Databases.

Journal: Biomedicines

Published: July 12, 2024

Evaluation of prognostic factors for late recurrence in clear cell renal carcinoma: an institutional study.

Evaluation of prognostic factors for late recurrence in clear cell renal carcinoma: an institutional study.

Journal: Frontiers in oncology

Published: June 10, 2024

Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients.

Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients.

Journal: International journal of environmental research and public health

Published: February 03, 2022

Pathological complete response following cisplatin or carboplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis.

Pathological complete response following cisplatin or carboplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis.

Journal: Experimental and therapeutic medicine

Published: August 06, 2021

Follow-up protocol for oncological patients at risk of developing multiple primary neoplasms.

Follow-up protocol for oncological patients at risk of developing multiple primary neoplasms.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: October 25, 2020

Challenges of pancreatic cancer chemotherapy in the COVID-19 era.

Challenges of pancreatic cancer chemotherapy in the COVID-19 era.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: May 09, 2020

Clinicopathological characteristics of patients with multiple primary neoplasms-a retrospective analysis.

Clinicopathological characteristics of patients with multiple primary neoplasms-a retrospective analysis.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: January 06, 2019

The impact of multiple primary neoplasms in daily practicea systematic review of the literature.

The impact of multiple primary neoplasms in daily practicea systematic review of the literature.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: March 20, 2018

The androgen receptor remains a key player in metastatic hormone-refractory prostate cancer. Implications for new treatments.

The androgen receptor remains a key player in metastatic hormone-refractory prostate cancer. Implications for new treatments.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: June 27, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026